What are the adenosine deaminase (ADA) cut‑off values for different body fluids (pleural, peritoneal/ascitic, pericardial, cerebrospinal, synovial) when evaluating suspected tuberculosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ADA Cut-off Values for Different Body Fluids in Suspected Tuberculosis

For diagnosing tuberculous involvement of body fluids, use the following ADA thresholds: pleural/peritoneal/pericardial fluids ≥40 U/L, and cerebrospinal fluid ≥9-10 U/L. 1

Fluid-Specific ADA Cut-off Values

Pleural Fluid

  • Standard threshold: 40 U/L provides optimal balance of sensitivity and specificity 1
  • At 40 U/L: sensitivity 92-94%, specificity 90% 2, 3
  • Lower threshold of 24 U/L can be used to lower probability of tuberculous pleural effusion but does not exclude it 4
  • In patients ≥40 years old, consider 30 U/L as alternative threshold (sensitivity 94.25%) 5
  • Note: ADA >40 U/L is recommended by multiple studies using this exact cut-off 2, 6

Peritoneal/Ascitic Fluid

  • Threshold: 36-40 U/L 1
  • At this range: sensitivity 100%, specificity 97% 1
  • Cut-off of 39.9-41.1 U/L validated specifically in cirrhotic patients with similar diagnostic performance 7
  • This threshold maintains high accuracy regardless of underlying cirrhosis 7

Pericardial Fluid

  • Threshold: 40 U/L 1
  • At 40 U/L: sensitivity 88-94%, specificity 68-83% 1, 8
  • Alternative lower threshold of 30 U/L increases sensitivity to 94% but reduces specificity to 68% 8
  • Consider using 40 U/L for better specificity in clinical practice 1, 6

Cerebrospinal Fluid (CSF)

  • Threshold: 9-10 U/L 1
  • At 9-10 U/L: sensitivity 79%, specificity 91% 1
  • Alternative threshold of 9.5 U/L provides optimal differentiation between tuberculous and non-tuberculous meningitis 9
  • Lower threshold of 4 U/L increases sensitivity to >93% but reduces specificity to <80% 1
  • Higher threshold of 8 U/L reduces sensitivity to <59% but increases specificity to >96% 1
  • For patients >7 years old, 0.15 μkat/L (approximately 9 U/L) shows sensitivity 100%, specificity 99% 6

Synovial Fluid

  • Threshold: >40 U/L 2
  • Limited data available, but same cut-off as pleural/peritoneal fluid appears appropriate 2

Critical Clinical Caveats

Interpretation Principles

  • ADA does not provide definitive diagnosis—it must be interpreted within the complete clinical context 1, 4
  • False-negative results delay treatment; false-positive results lead to unnecessary anti-tuberculous therapy and drug toxicity 1, 4
  • Tissue sampling for culture and sensitivity remains the gold standard for definitive diagnosis, regardless of ADA result 4

Common Pitfalls

  • Bilirubin interference: Increasing concentrations of conjugated and unconjugated bilirubin cause false elevations 10
  • Hyaluronidase interference: Certain sources (Sigma-Aldrich H3506) cause positive interference (4.59-17.90% elevation) 10
  • Age considerations: In patients ≥40 years, cancer becomes more common, and lower ADA thresholds (30 U/L) may be more appropriate for pleural fluid 5
  • Sample blanks should be processed to avoid false-positives (5.3% in CSF, 3.8% in pleural/peritoneal fluids) 6

Complementary Testing

  • IFN-γ levels can be measured in pleural and peritoneal fluids as adjunctive test 1
  • For pleural fluid: IFN-γ threshold 0.3-10 U/L or 12-300 pg/mL (sensitivity 89%, specificity 97%) 1
  • For peritoneal fluid: IFN-γ threshold 0.35-9 U/L or 20-112 pg/mL (sensitivity 93%, specificity 99%) 1
  • For pericardial fluid: IFN-γ >200 pg/L provides 100% sensitivity and specificity 8

Monitoring Treatment Response

  • CSF ADA decreases in time-dependent manner during successful anti-tuberculous therapy 9
  • Dynamic monitoring of CSF ADA may serve as indicator for evaluating treatment response 9

References

Guideline

Interpretation of Pleural Fluid ADA Levels in Tuberculosis Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Reappraisal of the Role of Ascitic Fluid Adenosine Deaminase for the Diagnosis of Peritoneal Tuberculosis in Cirrhosis.

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.